Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.44 -0.24%   SPY: 165.02 -0.55%
Quote Spy BIIB NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Biogen Idec (BIIB)

@ 11:07 AM
Click the portfolio to add BIIB:
Close [X]
+ Add BIIB to Portfolio
  
  Last Trade: $233.35 +0.28 (0.12%)
  Volume: 533,181 104% of avg daily volume
       
  Avg Volume: 1,389,046
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 226.01 - 233.54
  Open: 230.25
  Previous Close: 233.07
  52-wk Range: 126.39 - 238.83
  Market Cap: 55.3B
  P/E: 37.0
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (+0.2%)
Spy BIIB

? Pro holders
? Member holders
? Items submitted
Additional BIIB resources



Customize Links
To see which Pros and tickerspy members own BIIB Sign up now
Latest BIIB Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

MS Patients Choose Death Risk With Potent Drug Treatment
BIIB  ABBV  
Linked by Bloomberg - May 23, 08:57AM from (www.bloomberg.com)
Kari Antin, a 40-year-old financial analyst in Minneapolis, knows she’s taking a life-or-death risk with every monthly infusion of Biogen (BIIB) Idec Inc.’s Tysabri.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Biogen Idec nombra Director Científico a Spyros Artavanis-Tsakonas
BIIB  
Linked by BusinessWire - May 23, 08:00AM from (www.businesswire.com)
Biogen Idec (NASDAQ:BIIB) ha anunciado que Spyros Artavanis-Tsakonas, Ph.D., ha sido nombrado Director Científico de la  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Biogen Idec ernennt Spyros Artavanis-Tsakonas zum Chief Scientific Officer
BIIB  
Linked by BusinessWire - May 23, 08:00AM from (www.businesswire.com)
Biogen Idec (NASDAQ:BIIB) hat heute bekannt gegeben, dass Dr. Spyros Artavanis, Ph.D., zum Chief Scientific Officer (CSO)  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Teva Bets on Reformulating Old Drugs as Investors Say 'Show Me'
BMY  FRX  LLY  JNJ  BIIB  ALXA  
Linked by Bloomberg - May 21, 07:01AM from (www.bloomberg.com)
Teva Pharmaceutical Industries Ltd. (TEVA), which just two years ago was analysts’ highest-rated stock among the world’s  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Deutsche Bank Firm on Biotech Stocks to Buy
AMGN  CELG  REGN  BIIB  VRTX  GILD  ALXN  ONXX  DB  
Linked by 24/7 Wall St. - May 15, 08:10AM from (247wallst.com)
Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Interest in Vertex Rises, in Celgene Falls
BMY  PFE  JNJ  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  
Linked by Benzinga.com - May 11, 10:45AM from (www.benzinga.com)
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
S&P Highlights Biotech ETFs
ABT  JNJ  AMGN  CELG  BIIB  VRTX  GILD  NPSP  IBB  BBH  PJP  XBI  
Linked by Benzinga.com - May 10, 07:39AM from (www.benzinga.com)
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amgen Chased By The Bubble
ABT  PFE  MRK  AMGN  NVO  CELG  TEVA  BIIB  GILD  SNY  AFFY  HSP  
Linked by Investopedia Stock Analysis - May 08, 11:00AM from (www.investopedia.com)
Amgen really needs the pipeline to come through to support this valuation.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Three Sector ETFs Up 20% or More YTD
KO  PG  AMGN  CELG  BIIB  GILD  SPY  NFLX  GOOG  FXG  BBH  XLP  VDC  PBS  
Linked by Benzinga.com - May 03, 08:09AM from (www.benzinga.com)
The S&P 500 continued its flirtation with the psychologically important 1,600 level Thursday with a gain of almost  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
$50,000-a-Year MS Drugs: Pharma Growth Battle
BIIB  NVS  SNY  
Linked by YCHARTS - May 01, 04:32PM from (ycharts.com)
Here is one way to tell that the battle in the multiple sclerosis market is heating up. Now that Biogen Idec (BIIB) has successfully  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 47



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource